Home » Topics » Disease categories and therapies » Cardiovascular

Cardiovascular
RSS

Effects of 5-HT, TxA2 and their antagonists on restenosis

Oct. 20, 1997

Clinical results reported for 546C88 in septic shock

Oct. 20, 1997

Draflazine: a potential cardioprotectant with a novel mechanism of action

Oct. 17, 1997

Alpha1-antichymotrypsin analogues described in patent literature

Oct. 17, 1997

Do calcium channel blockers increase risk of cancer?

Oct. 16, 1997

Takeda's Blopress approved in EC

Oct. 16, 1997

Novel squalene synthase inhibitor reported by Pfizer

Oct. 15, 1997

Lenercept evaluated in phase II for sepsis/septic shock; development for RA halted

Oct. 15, 1997

New agent for restenosis reported by Taiho

Oct. 15, 1997

PRIME II: another heart failure drug associated with increased mortality

Oct. 15, 1997